NASDAQ:SIEN
Sientra Stock News
$0.174
+0 (+0%)
At Close: May 17, 2024
Sientra Reports Record Breast Products Revenue for Second Quarter 2021, Raises Revenue Guidance for Full Year 2021
04:01pm, Tuesday, 10'th Aug 2021
SANTA BARBARA, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company exclusively focused on plastic surgery, today a
Sientra Appoints Two Medical Aesthetics Leaders to its Board of Directors
08:00am, Monday, 19'th Jul 2021
SANTA BARBARA, Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today ann
Sientra Announces Appointment of Chief Financial Officer
08:00am, Monday, 12'th Jul 2021
SANTA BARBARA, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today ann
Sientra Announces Closing of Previously Announced Sale of miraDry Business to 1315 Capital
08:00am, Friday, 11'th Jun 2021
SANTA BARBARA, Calif., June 11, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today ann
Sientra Announces Addition of Vice President of Research & Development
04:01pm, Tuesday, 01'st Jun 2021
SANTA BARBARA, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra" or the “Company"), a medical aesthetics company uniquely focused on plastic surgeons, today announc
Wall Street Flies Away From Butterfly Networks After Its Second Earnings Report
10:11am, Thursday, 27'th May 2021
Despite on-target revenue growth, investors were not convinced about the medical device company's growth plans.
Sientra to Participate in Upcoming Virtual Investor Conferences
04:05pm, Tuesday, 18'th May 2021
SANTA BARBARA, Calif., May 18, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today anno
Sientra, Inc. (SIEN) CEO Ron Menezes on Q1 2021 Results - Earnings Call Transcript
10:56pm, Tuesday, 11'th May 2021
Sientra, Inc. (SIEN) CEO Ron Menezes on Q1 2021 Results - Earnings Call Transcript
Sientra Announces Sale of miraDry Business to 1315 Capital
04:01pm, Tuesday, 11'th May 2021
Transaction Enables Sharper Focus on Company's Rapidly Growing Breast Product Business Transaction Enables Sharper Focus on Company's Rapidly Growing Breast Product Business
Sientra's Earnings Outlook
10:11am, Monday, 10'th May 2021
On Tuesday, May 11, Sientra (NASDAQ:SIEN) will release its latest earnings report. Decipher the announcement with Benzinga's help.
Sientra and Butterfly Network Announce Strategic Partnership to Improve Diagnostic Surveillance of Breast Implant Patients
08:00am, Friday, 30'th Apr 2021
The partnership builds on Sientra's safety profile by empowering surgeons with Butterfly Network's cutting-edge point-of-care ultrasound technology to screen and evaluate patients with breast implants
The Highest-Momentum Holdings of the Decade's Top-Performing Gurus
06:31pm, Friday, 26'th Mar 2021
Investors often look to top fund managers to glean information on the best strategies and generate new investment ideas.
Sientra's (SIEN) CEO Ron Menezes on Q4 2020 Results - Earnings Call Transcript
09:43pm, Thursday, 11'th Mar 2021
Sientra's (SIEN) CEO Ron Menezes on Q4 2020 Results - Earnings Call Transcript
Sientra (SIEN) Reports Q4 Loss, Tops Revenue Estimates
06:10pm, Thursday, 11'th Mar 2021
Sientra (SIEN) delivered earnings and revenue surprises of -15.15% and 0.20%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Sientra Announces Departure of CFO and Appointment of Interim CFO
04:01pm, Thursday, 11'th Mar 2021
SANTA BARBARA, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today an
